Dravet syndrome in children-A population-based study

Area of Science:

• Pediatric Neurology
• Genetics
• Epidemiology

Background:

• Dravet Syndrome (DS) is a severe form of epilepsy with early onset.
• Genetic variants, particularly in the SCN1A gene, are the primary cause of DS.
• Understanding the epidemiology and clinical characteristics of DS is crucial for improving patient care.

Purpose of the Study:

• To describe the age at diagnosis, cumulative incidence, SCN1A variants, mortality, seizure types, and treatments in Swedish children with DS.
• To compare these characteristics between children born in different time periods to identify trends.

Main Methods:

• A population-based study included children diagnosed with DS born between 2000 and 2018 in Sweden.
• Data on clinical features, seizure types, and treatments were collected from caregivers and medical records.
• Statistical comparisons were made between two birth cohorts (2000-2009 and 2010-2018).

Main Results:

• A pathogenic SCN1A variant was identified in over 90% of the 53 studied children.
• Median age at diagnosis was significantly lower (1.6 years) in the 2010-2018 cohort compared to the 2000-2009 cohort (4.5 years).
• Cumulative incidence of DS was higher in the later cohort (1/33,000 vs 1/46,000), and the use of contraindicated sodium-channel inhibitors decreased.

Conclusions:

• Increased awareness of DS in Sweden has likely contributed to earlier diagnosis and improved management.
• Tonic seizures may be more prevalent in DS than previously reported.
• The findings highlight the importance of genetic testing and tailored treatment strategies for DS.